Solorank.ai
Login

Cached score snapshot

US.WST · West Pharmaceutical Services

110分制 42.3/110；5D動能v2 4/50；排序分 46.3/160

Back to ranking Open volume snapshot
Ranking score 46.3/160
Main score 42.3/110
5D momentum v2 4/50
Rank #492
Setup grade F 15.8

Score breakdown

避免

Elevated database-backfill

Score and price trend

F 15.8 Elevated risk

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 01-02 02-19 04-07 05-21 07-08 $212.32$295.75$379.17 Price Projection date
Historical projection
Model Median P25/P75 歷史相似情境上漲比例 Down5 Actual / compare
Rolling DOE best · score 1.561 · anchors 48 -0.43% -1.77% / +1.63% 43.8% 7.5% Actual -0.73% · vs median -0.30% · inside 25-75 band
Historical projection 10D n=160 +0.14% -1.73% / +2.33% 50.6% 8.1% Actual +4.71% · vs median +4.57% · inside 25-75 band

歷史情境統計基於已存檔相似 setup；圖中投影中位線為統計中位數的線性插值展示，並非價格路徑預測或買賣建議。

2026-01-02 → 2026-07-08 · 128 archived points · 2 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 46.3
Display grade 避免
Model version cursor_18_27_news_v2_160
Main score 42.3/110 (避免)
5D momentum v2 4/50 (弱)
Score with momentum v2 46.3/160 (低排序)
Risk level Elevated

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 152
ma20 262.004
ma50 267.9744
close 232.65
prevClose 235.89
avgVolume20 964920
volumeRatio 0.96
changePercent -1.37

Metrics snapshot

close 232.65
volume 930200
changePercent -1.37

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 42.3/110
Main rating 避免
5D momentum v2 4/50
Score with momentum v2 46.3/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 3.2/5 · 一般
Dimension score 3.2/5
Dimension grade 一般

Sub-items

pbPoints 0.2
pePoints 0.2
epsPoints 0
roePoints 0.6
debtPoints 0.5
marginPoints 0.4
turnoverUsdM 216.411
volumePoints 0.5
revenuePoints 0
dividendPoints 0.3
marketCapPoints 0.5

資金流 — 5.2/20 · 較差
Dimension score 5.2/20
Dimension grade 較差

Sub-items

cmfPoints 0.8
mfiPoints 0.8
obvPoints 0.8
vwapPoints 0.8

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.WST
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 9.2/15 · 一般
Dimension score 9.2/15
Dimension grade 一般

Sub-items

vix

score 2.4

details

source twelvedata+fred+database-backfill-market-proxy
vixClose 16.88

trend

score 4

details

qqq

ma20 122.6148
ma50 120.3368
name QQQ
close 123.6045
points 2

spy

ma20 113.5538
ma50 111.1755
name SPY
close 114.1602
points 2
source twelvedata+fred+database-backfill-market-proxy
atrPct 4.0987
atrPoints 2
cciPoints 0.8
vixPoints 2.4
marketTrendPoints 4

催化劑 — 2/20 · 較差
Dimension score 2/20
Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model
articleCount 8
catalystCount 0
catalystPoints 2

風險管理 — 5.7/10 · 較差
Dimension score 5.7/10
Dimension grade 較差

Sub-items

position

score 1.1

details

atrPct 4.0987
turnoverUsdM 216.411
liquidityPoints 0.4
volatilityPoints 0.7
rrPoints 1.4

stopLevels

symbol US.WST
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 213.5786

strength_details

ma_score 1
atr_score 1
rsi_score 2.5
macd_score 1
volume_score 1
market_adjustment 1
risk_reward_ratio 1
stop_loss_percent 8.2
take_profit_price 245.8728
target_multiplier 1.6
technical_strength 1.3
take_profit_percent 5.7
positionPoints 1.1
stopLossPoints 1.2

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 8.1975
diversificationPoints 2

技術信號 — 11/30 · 較差
Dimension score 11/30
Dimension grade 較差

Sub-items

bbPoints 2.4
adxPoints 3
sarPoints 1.2
vcpPoints 0.5
macdPoints 0.8

vcpPayload

vcp_pass false
vcp_score 0.5
vcp_reason 升放量(近10日2日)；Ready=N；Confirm=N

vcp_metrics

up_days 3
vol_ref 861046.6667
down_days 6
vcp_ready false
above_ma50 false
avg_vol_10 1229380
avg_vol_20 936240
avg_vol_30 861046.6667
range_pct_10 0.2127
range_pct_20 0.255
range_pct_30 0.255
up_expand_ok true
lookback_used 79
near_20d_high false
contraction_ok false
down_shrink_ok false
up_expand_days 2
breakout_20d_ok false
vol_ratio_10_30 1.4278
dist_to_20d_high 0.2016
down_shrink_days 1
breakout_level_20d 291.38
vcp_breakout_confirm false
contraction_ratio_10_30 0.8343
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction false
kdjAdxPoints 0.5
rsiKdjPoints 0.8
volumeWeight 2
maCrossPoints 0
shortRsiPoints 0
shortMacdPoints 0.4
volConfirmPoints 0.6
volumePointsTechnical 0.8

情緒分析 — 6/10 · 一般
Dimension score 6/10
Dimension grade 一般

Sub-items

sentiment

score 6

details

source finnhub_news_keyword_model
articleCount 8
negativeHits 0
positiveHits 4
sentimentScoreRaw 1.2

sentimentData

raw {"id":140686517,"url":"https://finnhub.io/api/news?id=c45fa16b883b56b09f51b1545b23e20502ab16065766ea6582c6474cef1bcaaf","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"West Pharmaceutical Services (WST) stock has drawn attention after recent share price moves, with investors weighing its role in drug containment and delivery in relation to current valuation signals and recent returns over the past month and past 3 months. See our latest analysis for West Pharmaceutical Services. At a share price of $327.95, West Pharmaceutical Services has seen strong momentum build over the past quarter, with a 35.85% 3 month share price return and a 52.46% 1 year total...","category":"company","datetime":1782065240,"headline":"West Pharmaceutical Services (WST) Stock Could Be 6.9% Undervalued on GLP 1 Growth Narrative"}, {"id":140641821,"url":"https://finnhub.io/api/news?id=2bcf0b980697bdd68bd35d50bc5c863ee6dd8914bd2951100d61af11d76c6ed7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"West Pharmaceutical Services recently reported strong first-quarter 2026 results, highlighting robust growth in biologics-related high-value components and self-injection delivery devices, and raised its full-year 2026 revenue and adjusted EPS guidance. The company emphasized its role as a critical part of injectable-drug infrastructure rather than a conventional packaging supplier, underlining how its specialized high-value products support complex biologic therapies. Next, we’ll examine...","category":"company","datetime":1781572160,"headline":"How Investors May Respond To West Pharmaceutical Services (WST) Upgraded 2026 Outlook And Biologics Momentum"}, {"id":140588081,"url":"https://finnhub.io/api/news?id=f2cf94bb03b8b2b5e729f6d1843e2f16c0cdf55e30b710fb5426d2240c9c7cc8","image":"","source":"Fintel","related":"WST","summary":"","category":"company","datetime":1781047666,"headline":"Barclays Upgrades West Pharmaceutical Services (WST)"}, {"id":140595179,"url":"https://finnhub.io/api/news?id=562c9de279ec4933fe1d981ae426245f1dfc1fafd419982c3aaf1d713c6bfd6d","image":"https://image.cnbcfm.com/api/v1/image/108319218-17810424221781042420-46447529485-1080pnbcnews.jpg?v=1781042422&w=1920&h=1080","source":"CNBC","related":"WST","summary":"The final trades of the day with CNBC's Melissa Lee and the 'Fast Money' traders.","category":"company","datetime":1781028187,"headline":"Final Trade: WST, URI, SMH, MCD"}, {"id":140577352,"url":"https://finnhub.io/api/news?id=f0807d13a6f900cfc94a56be7ed5f28a34388820525ad4087e3c8f5e2c4cbaf9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"With a net profit margin of 16.85%, West Pharmaceutical Services, Inc. (NYSE:WST) is included among the 10 Most Profitable Dividend Stocks to Invest In Now. Wolfe Research analyst Mike Polark upgraded West Pharmaceutical Services, Inc. (NYSE:WST) to Outperform from Peer Perform on June 2. He also assigned a $375 price target to the stock. The analyst […]","category":"company","datetime":1780976158,"headline":"Wolfe Research Says West Pharmaceutical Services (WST) is Positioned to Benefit from Injectable Drug Growth"}, {"id":140560483,"url":"https://finnhub.io/api/news?id=213465d7d38c064deb83e491ca79c6de5df36e0ae864720233ae4bdbe2274a7b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"West Pharmaceutical Services Inc (NYSE:WST) is one of the best stocks to buy according to billionaire Bill Gates. WST stock is up around 14% year-to-date and has gained nearly 50% over the past year. Analysts still see upside potential in the stock. On May 31, Wolfe Research initiated coverage of West Pharmaceutical Services Inc (NYSE:WST) […]","category":"company","datetime":1780854489,"headline":"Wolfe Research Weighs on West Pharmaceutical Services Inc (WST) Stock"}, {"id":140560484,"url":"https://finnhub.io/api/news?id=624aaed2b48741460274ab9dc9e8612a0c2934308a5b072f9187cbcdc1b01cd8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"The updated analyst narrative for West Pharmaceutical Services now reflects a fair value estimate of US$352.36 per share, up from US$349.85. This refinement sits alongside fresh company guidance for Q2 2026 net sales, a recent buyback of 1,222,019 shares for US$297.65 million, and an announced leadership transition planned for the second half of 2026. Read on to see how these moving parts fit together and how you can keep track of the evolving story. Wall Street's queuing for one rocket...","category":"company","datetime":1780851992,"headline":"How The West Pharmaceutical Services (WST) Story Is Evolving With Guidance Buybacks And New Leadership"}, {"id":140520222,"url":"https://finnhub.io/api/news?id=ce828ac4c9c92407eae58dd8869c1d76da721bf6460f19af62789834939ff7c6","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"WST","summary":"2026-06-04. The following slide deck was published by West Pharmaceutical Services, Inc.","category":"company","datetime":1780542088,"headline":"West Pharmaceutical Services, Inc. (WST) Presents at 46th Annual William Blair Growth Stock Conference - Slideshow"}
raw_source {"id":140686517,"url":"https://finnhub.io/api/news?id=c45fa16b883b56b09f51b1545b23e20502ab16065766ea6582c6474cef1bcaaf","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"West Pharmaceutical Services (WST) stock has drawn attention after recent share price moves, with investors weighing its role in drug containment and delivery in relation to current valuation signals and recent returns over the past month and past 3 months. See our latest analysis for West Pharmaceutical Services. At a share price of $327.95, West Pharmaceutical Services has seen strong momentum build over the past quarter, with a 35.85% 3 month share price return and a 52.46% 1 year total...","category":"company","datetime":1782065240,"headline":"West Pharmaceutical Services (WST) Stock Could Be 6.9% Undervalued on GLP 1 Growth Narrative"}, {"id":140670839,"url":"https://finnhub.io/api/news?id=67b3a881297b7772c29c5238e360566a31094107768093e0f084d29a29891adf","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"TXG collaborates with the Cleveland Clinic to advance bladder cancer diagnostics using Flex Apex, Xenium and potentially Atera.","category":"company","datetime":1781879460,"headline":"10x Genomics, Cleveland Clinic Team Up on Bladder Cancer Diagnostics"}, {"id":140670840,"url":"https://finnhub.io/api/news?id=c6a7812f159ccb5aaef45ee570ae7d8e2b9f14fd8e26006ea81049dde42451b5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"BAX gains as Synovis MCA signs a multi-year deal to commercialize MediThinQ's SHIYA 3D surgical visualization platform worldwide.","category":"company","datetime":1781878980,"headline":"Baxter's Unit Synovis MCA to Lead Global Rollout of the SHIYA Platform"}, {"id":140670077,"url":"https://finnhub.io/api/news?id=77483a1986c2444fbad0d762dfd0ec0e9346104b5c753aa6dfc4083fdbd21d63","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"Cardinal Health has gained nearly 8% in 2026 as specialty pharma growth, rising EPS, and expanding healthcare services fuel investor optimism.","category":"company","datetime":1781872560,"headline":"CAH Stock Up Nearly 8% YTD: Will the Uptrend Continue in the Rest of 2026?"}, {"id":140664196,"url":"https://finnhub.io/api/news?id=44be2be72418cae135bcebd527ed2c7099c025f77f83a5ccac5939b911f80b2b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"COR shares are down 18% YTD, but rising EPS guidance, specialty pharma growth and strategic expansion could make this pullback worth watching.","category":"company","datetime":1781801340,"headline":"COR Stock Down Nearly 18% YTD: Should You Buy, Hold or Sell?"}, {"id":140663236,"url":"https://finnhub.io/api/news?id=54c47bc52510c4e70318b2b62ce1fb07e7599da324ff0847e8fd38a8edc0e03c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"COR's enhanced Nucleus platform targets complex specialty medication workflows, with a pilot underway across more than 20 physician practice sites.","category":"company","datetime":1781793180,"headline":"Cencora Launches Enhanced Nucleus Solution for Specialty Practices"}, {"id":140663276,"url":"https://finnhub.io/api/news?id=9c6bc3e6685dd167ee737b80671b69ce4b3fbf27f24e0fe6e1772a57ac74527f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"AngioDynamics' FDA IDE approval for RELIEF advances NanoKnife IRE study as a potential minimally invasive BPH treatment.","category":"company","datetime":1781790720,"headline":"ANGO Gains FDA IDE Approval for NanoKnife BPH Feasibility Study"}, {"id":140655101,"url":"https://finnhub.io/api/news?id=c6820df331bb939fd0a563fc99c4f276fe5209059cfa807223eeb2aba2ebe109","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"QDEL's strong portfolio, cost-saving progress and mixed first-quarter results support growth, though respiratory reliance remains a risk.","category":"company","datetime":1781709360,"headline":"Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now"}, {"id":140653696,"url":"https://finnhub.io/api/news?id=25acde4485ef5b4d91cc6eefe2ef7f92cb071df76329d0ed90613b00e4ce091e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"LIVN's PolySync data show an 84.5% AHI response rate in OSA patients, building on OSPREY results for its aura6000 System.","category":"company","datetime":1781705640,"headline":"LivaNova Reports Improved OSA Outcomes With PolySync Programming"}, {"id":140648039,"url":"https://finnhub.io/api/news?id=15d6a6da3b9d3800527810852b9cb36443de1cbe24001fad935a1b3e373c974f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"BAX is pursuing a broad turnaround as innovation, resilient demand, and AI integration support recovery despite regulatory risks and margin pressure.","category":"company","datetime":1781633640,"headline":"Reasons to Retain Baxter International Stock in Your Portfolio for Now"}, {"id":140647069,"url":"https://finnhub.io/api/news?id=57f1f61b15e61892ad7b0d9677ac4ee53002c5b993308bacb0aeace1d83807f9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"NSPR's positive CGUARDIANS II data show 100% acute device success, supporting a potential FDA approval for CGuard Prime TCAR in late 2026.","category":"company","datetime":1781628060,"headline":"InspireMD Posts Positive CGUARDIANS II Data for CGuard Prime TCAR"}, {"id":140645762,"url":"https://finnhub.io/api/news?id=a8d63b72d303e6561b81214e4faddf0c3ad8576ea34cddd328f137ea21e8e67d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"DexCom's FDA-cleared Stelo OTC glucose biosensor now covers children aged above 2 years not using insulin, expanding access to smartphone-linked CGM insights.","category":"company","datetime":1781618100,"headline":"DXCM Receives FDA Clearance for Stelo OTC CGM System for Children"}, {"id":140645722,"url":"https://finnhub.io/api/news?id=8609db04e140777425e1b39bcadd535acf2b839741f5f4815bf0bf3fcc060be3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"Becton, Dickinson's MedTech focus, innovation push and strategic partnerships support growth optimism, though reimbursement uncertainty remains a key concern.","category":"company","datetime":1781618040,"headline":"Here's Why You Should Retain BDX Stock in Your Portfolio Now"}, {"id":140641821,"url":"https://finnhub.io/api/news?id=2bcf0b980697bdd68bd35d50bc5c863ee6dd8914bd2951100d61af11d76c6ed7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"West Pharmaceutical Services recently reported strong first-quarter 2026 results, highlighting robust growth in biologics-related high-value components and self-injection delivery devices, and raised its full-year 2026 revenue and adjusted EPS guidance. The company emphasized its role as a critical part of injectable-drug infrastructure rather than a conventional packaging supplier, underlining how its specialized high-value products support complex biologic therapies. Next, we’ll examine...","category":"company","datetime":1781572160,"headline":"How Investors May Respond To West Pharmaceutical Services (WST) Upgraded 2026 Outlook And Biologics Momentum"}, {"id":140639070,"url":"https://finnhub.io/api/news?id=f5600064373a72432725385186e30bfca82b04dc591c663e50d057d4052fd67a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"QGEN's QIAcuity expansion adds gene expression assays, multiplexing, automation and analysis tools to drive dPCR adoption.","category":"company","datetime":1781536560,"headline":"QIAGEN Expands QIAcuity Gene Expression Portfolio to Drive dPCR Use"}, {"id":140638230,"url":"https://finnhub.io/api/news?id=64cb42c51cfc3a9a64d381a8a82b83a57307d72c071ebeff543fedd59840459c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"GE HealthCare expands its Carilion Clinic collaboration with AAMP and Encompass to improve equipment management and operational efficiency across Virginia.","category":"company","datetime":1781535000,"headline":"GEHC Expands Carilion Tie to Enhance Patient Care Across Virginia"}, {"id":140637328,"url":"https://finnhub.io/api/news?id=47736f5137f3207a02d96c00e27f877870297de1fbe90a74ad6d1cca3d437c30","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"West Pharmaceutical continues to outpace broader market gains on strong earnings momentum and supportive analyst sentiment.","category":"company","datetime":1781506536,"headline":"Is West Pharmaceutical Stock Outperforming the S&P 500?"}, {"id":140621746,"url":"https://finnhub.io/api/news?id=d41d25da43b74e3068e20e63e981f5de87afdbf670dc0272d399431273931bb8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"Stryker faces cyberattack fallout, but strong procedure demand, record Mako adoption and global expansion continue to support long-term growth.","category":"company","datetime":1781284560,"headline":"Here's Why You Should Hold Stryker Stock in Your Portfolio for Now"}, {"id":140620400,"url":"https://finnhub.io/api/news?id=75037c34a442a251bd2fc892e46eae16ae7cd126e4828d381b146e8aa3035172","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"VEEV's UCB pharmacovigilance deal expands Safety Suite adoption, supporting automation, compliance and long-term growth opportunities.","category":"company","datetime":1781276940,"headline":"Veeva Expands Safety Suite Footprint With UCB Pharmacovigilance Deal"}, {"id":140620404,"url":"https://finnhub.io/api/news?id=e98d9a5f89955a1d56754c58dff390c94641534b95b0427387b54b37a4bcaebf","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"HQY benefits from strong HSA growth, AI-driven automation and solid first-quarter fiscal 2027 results despite data security risks.","category":"company","datetime":1781276760,"headline":"Reasons to Hold HealthEquity Stock in Your Portfolio for Now"}, {"id":140618921,"url":"https://finnhub.io/api/news?id=e08c22750b7d6f78f92d4852e6c3f42d1c475c88ab2cf11a25aa7305ede35077","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"OGN's TOFIDENCE gains FDA approval for life-threatening CRS and certain hospitalized COVID-19 patients, broadening its critical-care role.","category":"company","datetime":1781270100,"headline":"Organon Wins FDA Nod to Expand TOFIDENCE Use in Severe CRS & COVID-19"}, {"id":140609317,"url":"https://finnhub.io/api/news?id=0b61c1b7cd82674e2b54e6af7d021d35169efb1e197b734b68dc4aac8899296d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"SENS partners with Welldoc on a next-gen Eversense 365 app, adding Apple Health/Google Health Connect integration ahead of the U.S. launch.","category":"company","datetime":1781197560,"headline":"Senseonics Expands Eversense 365 Ecosystem With Welldoc Partnership"}, {"id":140607396,"url":"https://finnhub.io/api/news?id=4eb12ea0b2496c6afcfb326c0e00e56e23f3b85b409353f4e1061c29fa273987","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"HNGE expands HingeSelect to include orthopedic surgery, aiming to deliver coordinated end-to-end MSK care from imaging to post-op recovery.","category":"company","datetime":1781187540,"headline":"Hinge Health Expands HingeSelect to Offer End-to-End MSK Surgical Care"}, {"id":140597695,"url":"https://finnhub.io/api/news?id=04be83266d4dc472ff2093bf24f6d86adf2e21af82f8afadd1a6cf0cb580fada","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"10x Genomics stock rises after acquiring Proteintech Genomics, adding high-plex proteomics tools that strengthen multiomics research and support platform adoption.","category":"company","datetime":1781111040,"headline":"TXG Gains From Proteintech Deal, Expands Multiomics Capabilities"}, {"id":140596135,"url":"https://finnhub.io/api/news?id=be1d78fa564e9e85530462a79e73bf9a0d945cb4a049ea9a7a45c5d52edd8399","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"VEEV's strong Q1, growing Vault CRM migrations and AI expansion support growth, though life sciences CRM market saturation poses risks.","category":"company","datetime":1781110740,"headline":"Reasons to Add Veeva Systems Stock to Your Portfolio for Now"}, {"id":140594177,"url":"https://finnhub.io/api/news?id=394e401e88c6fe79926058b87ac0b55d27ac77c7d00c881953ecdb67150362b8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"NPCE rides strong RNS adoption and AI tools nearing FDA review, with a mid-2026 IGE decision offering upside despite near-term losses.","category":"company","datetime":1781102280,"headline":"Here's Why You Should Add NeuroPace Stock to Your Portfolio Now"}, {"id":140594178,"url":"https://finnhub.io/api/news?id=a32b20b8fcb710eee7fb6d1d490938674b31a2b22daa764fb9412dcf6f4f75c8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"AMN Healthcare acquires Jaide Health to add AI-powered interpretation and translation, widening language access across more healthcare touchpoints.","category":"company","datetime":1781102160,"headline":"AMN Expands Language Services Portfolio With Jaide Health Deal"}, {"id":140588081,"url":"https://finnhub.io/api/news?id=f2cf94bb03b8b2b5e729f6d1843e2f16c0cdf55e30b710fb5426d2240c9c7cc8","image":"","source":"Fintel","related":"WST","summary":"","category":"company","datetime":1781047666,"headline":"Barclays Upgrades West Pharmaceutical Services (WST)"}, {"id":140589643,"url":"https://finnhub.io/api/news?id=bcc959a3c7e1e0be16f14bc6c45755af87a23723537381f05dd09eb76f7a7ffd","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -0.26%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.17%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.12%. June E-mini S&P futures (ESM26 ) fell -0.36%, and June E-mini Nasdaq futures...","category":"company","datetime":1781037276,"headline":"Broader Market Settles Lower as Chip Stocks Sink"}, {"id":140584417,"url":"https://finnhub.io/api/news?id=5d919263361adc34d9b2d860affbcd2effa99ebafb7d49fc3e9a84863a15bd74","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"WST","summary":"Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.","category":"company","datetime":1781031900,"headline":"Top S&P500 movers in Tuesday's session"}, {"id":140595179,"url":"https://finnhub.io/api/news?id=562c9de279ec4933fe1d981ae426245f1dfc1fafd419982c3aaf1d713c6bfd6d","image":"https://image.cnbcfm.com/api/v1/image/108319218-17810424221781042420-46447529485-1080pnbcnews.jpg?v=1781042422&w=1920&h=1080","source":"CNBC","related":"WST","summary":"The final trades of the day with CNBC's Melissa Lee and the 'Fast Money' traders.","category":"company","datetime":1781028187,"headline":"Final Trade: WST, URI, SMH, MCD"}, {"id":140586782,"url":"https://finnhub.io/api/news?id=013c492ea1177f0c3f9567fa2d3922db467343d1a94cb1300e7ea4dd4369a0cc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"The S&P 500 Index ($SPX ) (SPY ) today is down -0.28%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.80%. June E-mini S&P futures (ESM26 ) are down -0.25%, and June E-mini Nasdaq futures...","category":"company","datetime":1781018614,"headline":"Stocks Erase Early Gains as Chipmakers Turn Lower"}, {"id":140585270,"url":"https://finnhub.io/api/news?id=071e4439ba6f7c7a02031814c060678dbc089041f0a1d66d87162879ad1639e0","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"The S&P 500 Index ($SPX ) (SPY ) today is up +0.93%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.89%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.17%. June E-mini S&P futures (ESM26 ) are up +0.76%, and June E-mini Nasdaq futures...","category":"company","datetime":1781014097,"headline":"Stocks Climb on an AI-Led Rebound"}, {"id":140582299,"url":"https://finnhub.io/api/news?id=fb6f13d08b877506eee8ba1556c9c2305e7b73adbdfdf44d203c6b6b2cbdd90b","image":"https://image.cnbcfm.com/api/v1/image/108318920-17810228181781022815-46442812417-1080pnbcnews.jpg?v=1781022817&w=1920&h=1080","source":"CNBC","related":"WST","summary":"The Investment Committee debate the latest Calls of the Day.","category":"company","datetime":1781008925,"headline":"Calls of the Day: Health Care and Materials"}, {"id":140579796,"url":"https://finnhub.io/api/news?id=2c80a8780cd086fbb7f801f79dfa446501a8bfc3e5d4da90e8f9330862392242","image":"https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp","source":"ChartMill","related":"WST","summary":"Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.","category":"company","datetime":1781008500,"headline":"Stay updated with the S&P500 stocks that are on the move in today's pre-market session."}, {"id":140579570,"url":"https://finnhub.io/api/news?id=57060f44c3c7608cab5ed0daaed5e30d5abfff1b2239ef0cb781d5059dcb8697","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"Pre-Market Stock Futures: Futures are trading higher after the bulls tried to rally stocks on Monday, after the drubbing they took on Friday, and it looks the same way today. While it was a partial victory on Monday, by the close, the huge gains from the morning were cut in half, and the Dow Jones ... Here Are Tuesday’s Top Wall Street Analyst Research Calls: Cerebras Systems, Cleveland-Cliffs, Equity Residential, FuelCell Energy, Lennar, Luckin Coffee, Toll Brothers, and More","category":"company","datetime":1781006280,"headline":"Here Are Tuesday’s Top Wall Street Analyst Research Calls: Cerebras Systems, Cleveland-Cliffs, Equity Residential, FuelCell Energy, Lennar, Luckin Coffee, Toll Brothers, and More"}, {"id":140580749,"url":"https://finnhub.io/api/news?id=693d2424a535a5e2af172ea1750a6085618ce14d58c53eb4be46b008fb605916","image":"https://cdn.benzinga.com/files/images/story/2026/06/09/Analyst-Works-On-Personal-Computer-Showi.jpeg?width=2048&height=1536","source":"Benzinga","related":"WST","summary":"Wall Street analysts upgraded AJG & BRC. See analyst rating changes & how they view BRC stock.","category":"company","datetime":1780998208,"headline":"This Brady Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday"}, {"id":140580781,"url":"https://finnhub.io/api/news?id=97225e73910a80f9647f6c424811b66a25497906c5a22e0740b3dcc673780e02","image":"","source":"Benzinga","related":"WST","summary":"Barclays analyst Luke Sergott upgrades West Pharmaceutical Servs (NYSE:WST) from Equal-Weight to Overweight and raises the price target from $310 to $400.","category":"company","datetime":1780996242,"headline":"Barclays Upgrades West Pharmaceutical Servs to Overweight, Raises Price Target to $400"}, {"id":140577352,"url":"https://finnhub.io/api/news?id=f0807d13a6f900cfc94a56be7ed5f28a34388820525ad4087e3c8f5e2c4cbaf9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"With a net profit margin of 16.85%, West Pharmaceutical Services, Inc. (NYSE:WST) is included among the 10 Most Profitable Dividend Stocks to Invest In Now. Wolfe Research analyst Mike Polark upgraded West Pharmaceutical Services, Inc. (NYSE:WST) to Outperform from Peer Perform on June 2. He also assigned a $375 price target to the stock. The analyst […]","category":"company","datetime":1780976158,"headline":"Wolfe Research Says West Pharmaceutical Services (WST) is Positioned to Benefit from Injectable Drug Growth"}, {"id":140572797,"url":"https://finnhub.io/api/news?id=f3ae8e0e7ff1289ad266adc145830d785a452d195d081cf0fb84b57585011dfe","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"DXCM reports positive CONNECT trial results as Dexcom G7 improves HbA1c and time in range in adults with Type 2 diabetes not using insulin.","category":"company","datetime":1780939740,"headline":"DexCom Reports Positive CONNECT Data for Non-Insulin Diabetes"}, {"id":140571185,"url":"https://finnhub.io/api/news?id=6febccff9e92b0b0fc22342b88808621fa97975fcb1725038dae6115ffe0f58c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"MMSI leans on therapeutic strength, an oncology acquisition and a new stent launch, but tariffs, OEM weakness and China pressure shadow 2026.","category":"company","datetime":1780933920,"headline":"Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now"}, {"id":140571186,"url":"https://finnhub.io/api/news?id=45634515759aa264e22ecc0b29b417f9dc3d2a7226e764e5b7c1ee84db93aa55","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"Natera teams with CytoDyn to track ctDNA in CLOVER Phase 2, using Signatera to map leronlimab response in metastatic colorectal cancer.","category":"company","datetime":1780933680,"headline":"NTRA & CytoDyn Partner to Advance ctDNA-Guided Development in mCRC"}, {"id":140565883,"url":"https://finnhub.io/api/news?id=ff7bc405867f5d2d57afcfe438453133658c30769539900c2f89015433e6159e","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2238324635/image_2238324635.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"WST","summary":"A curated universe of 50 high-quality dividend growth stocks identifies attractive entry points based on valuation and forward return potential. Check out the list here.","category":"company","datetime":1780894271,"headline":"Top 50 High-Quality Dividend Growth Stocks For June 2026"}, {"id":140560483,"url":"https://finnhub.io/api/news?id=213465d7d38c064deb83e491ca79c6de5df36e0ae864720233ae4bdbe2274a7b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"West Pharmaceutical Services Inc (NYSE:WST) is one of the best stocks to buy according to billionaire Bill Gates. WST stock is up around 14% year-to-date and has gained nearly 50% over the past year. Analysts still see upside potential in the stock. On May 31, Wolfe Research initiated coverage of West Pharmaceutical Services Inc (NYSE:WST) […]","category":"company","datetime":1780854489,"headline":"Wolfe Research Weighs on West Pharmaceutical Services Inc (WST) Stock"}, {"id":140560484,"url":"https://finnhub.io/api/news?id=624aaed2b48741460274ab9dc9e8612a0c2934308a5b072f9187cbcdc1b01cd8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"The updated analyst narrative for West Pharmaceutical Services now reflects a fair value estimate of US$352.36 per share, up from US$349.85. This refinement sits alongside fresh company guidance for Q2 2026 net sales, a recent buyback of 1,222,019 shares for US$297.65 million, and an announced leadership transition planned for the second half of 2026. Read on to see how these moving parts fit together and how you can keep track of the evolving story. Wall Street's queuing for one rocket...","category":"company","datetime":1780851992,"headline":"How The West Pharmaceutical Services (WST) Story Is Evolving With Guidance Buybacks And New Leadership"}, {"id":140538722,"url":"https://finnhub.io/api/news?id=ad27267a41303855f19475c950ff3f67fe4301be6b6442dd863342c993648e61","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"Cooper Companies beats Q2 EPS and sales estimates as CooperVision and CooperSurgical hit record revenues, even with a GAAP loss from recall litigation.","category":"company","datetime":1780673880,"headline":"COO Stock Rises on Q2 Earnings Beat, FY26 Revenue Guidance Trimmed"}, {"id":140538723,"url":"https://finnhub.io/api/news?id=0702798f8e3683b4455d8c179399e7497cb45d75fdd3fca436c501893ff5f49f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"Fresenius Medical Care launches kinexus, a home dialysis platform integrating remote monitoring, prescription management and supply ordering for PD and HHD.","category":"company","datetime":1780673460,"headline":"FMS Launches kinexus Digital Platform for Home Dialysis Care"}, {"id":140536761,"url":"https://finnhub.io/api/news?id=e2ab2306c3de68e6b7105a7966bc3fe0db0bf058bd4a7d9bed4a6788cbba38a0","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"GEHC wins FDA clearance for AI-powered radiation planning software, adding new clinical models and a pathway for faster future updates.","category":"company","datetime":1780665780,"headline":"GE HealthCare Gains FDA Clearance for AI Radiation Planning Software"}, {"id":140527622,"url":"https://finnhub.io/api/news?id=c153492ac08ff08c921bb41a0473cad843f2b266789d64fe8c26b060dccf050b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"DXCM banks on CGM market growth, expanding international demand and strong Q1 momentum, though competitive pressures remain a key risk.","category":"company","datetime":1780596480,"headline":"Here's Why You Should Retain DexCom Stock in Your Portfolio"}, {"id":140527625,"url":"https://finnhub.io/api/news?id=6c429bc7f54211872429a8f1198ac780e85f8eec452186d15f6f4fdb78425292","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"Veeva Systems beats Q1 earnings and revenue estimates, raises fiscal 2027 guidance, and expands AI offerings as adoption of its software platforms expands.","category":"company","datetime":1780596000,"headline":"VEEV Stock Down Despite Q1 Earnings & Revenues Beat Estimates"}, {"id":140525722,"url":"https://finnhub.io/api/news?id=56d7fbb3dd9495daa15f3f44eacf5d3bddff04930e3bf2c74e41665b8425264f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.","category":"company","datetime":1780593930,"headline":"3 Profitable Stocks with Open Questions"}, {"id":140525723,"url":"https://finnhub.io/api/news?id=3968fbc00a0bf492b7ff276f3804cf730e53ac8055fc1d60d481964975726844","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1780587016,"headline":"Why Is Henry Schein (HSIC) Up 4.6% Since Last Earnings Report?"}, {"id":140523690,"url":"https://finnhub.io/api/news?id=06d9bb0ed8a12e7287c2c0622182292e3b4f634cb45e1043cf11ca1cd7115b82","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"SYK launches TPX HD, a small bone power tool built for complex revisions, MIS and oral maxillofacial cases with higher torque and speed.","category":"company","datetime":1780582980,"headline":"Stryker Launches TPX HD Power Tool for Complex Orthopedic Procedures"}, {"id":140520222,"url":"https://finnhub.io/api/news?id=ce828ac4c9c92407eae58dd8869c1d76da721bf6460f19af62789834939ff7c6","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"WST","summary":"2026-06-04. The following slide deck was published by West Pharmaceutical Services, Inc.","category":"company","datetime":1780542088,"headline":"West Pharmaceutical Services, Inc. (WST) Presents at 46th Annual William Blair Growth Stock Conference - Slideshow"}, {"id":140516318,"url":"https://finnhub.io/api/news?id=4b62cb593bd59e32a2483bdaeb8f4ba062a24ab09d80deb1aebc46a949d0d2b7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"PACB's growth is supported by HiFi sequencing advances and product momentum, though funding pressures weigh on instrument demand.","category":"company","datetime":1780508580,"headline":"Here's Why You Should Add PacBio Stock to Your Portfolio Now"}, {"id":140507158,"url":"https://finnhub.io/api/news?id=acd00d192216777c2800d6a0f12795cdc6c11830248f8dc52168f3554c9c1c40","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"WST","summary":"West Pharmaceutical Services, Inc. (WST) 46th Annual William Blair Growth Stock Conference June 2, 2026 5:00 PM EDTCompany ParticipantsEric Green -...","category":"company","datetime":1780427513,"headline":"West Pharmaceutical Services, Inc. (WST) Presents at 46th Annual William Blair Growth Stock Conference Prepared Remarks Transcript"}, {"id":140502662,"url":"https://finnhub.io/api/news?id=ddf6e8145494fe589a6f7cfb39965e2d8b318dff95a9437a33546d81f2fcbc2e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"AMN Healthcare is riding MSP momentum, labor disruption demand and AI platforms, yet faces pricing pressure and post-disruption volatility.","category":"company","datetime":1780415940,"headline":"Here's Why You Should Retain AMN Stock in Your Portfolio for Now"}, {"id":140502663,"url":"https://finnhub.io/api/news?id=74d8edf2de013e3d5a091c45a81f7a890cad8dc2cc24eb5445cec5a0de77a4a2","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"NeuroPace wins FDA OK for ECoG Assistant, its first AI feature for epilepsy care, leveraging RNS EEG data to speed ECoG review and insights.","category":"company","datetime":1780415400,"headline":"NPCE Receives FDA Approval for AI-Powered ECoG Assistant for Epilepsy"}, {"id":140502246,"url":"https://finnhub.io/api/news?id=e636a17a5c506931403f8c9acd0bb62ac776b085fc858f38332091ccdadafe37","image":"","source":"Benzinga","related":"WST","summary":"Stephens & Co. analyst Steven Etoch reiterates West Pharmaceutical Servs (NYSE:WST) with a Overweight and maintains $360 price target.","category":"company","datetime":1780390097,"headline":"Stephens & Co. Reiterates Overweight on West Pharmaceutical Servs, Maintains $360 Price Target"}, {"id":140502247,"url":"https://finnhub.io/api/news?id=d7bf6edac320216b9740fe32514bc8461a205ee6f62fe0a5a3f1c83633723bff","image":"","source":"Benzinga","related":"WST","summary":"Wolfe Research analyst Mike Polark assumes West Pharmaceutical Servs (NYSE:WST) with a Outperform rating.","category":"company","datetime":1780389057,"headline":"Wolfe Research Assumes West Pharmaceutical Servs at Outperform"}, {"id":140493471,"url":"https://finnhub.io/api/news?id=a1c2edf502bfb2859b83b8849116be44b8e1d88763cb8fcca14e95fc01ec2bdc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its Board of Directors has appointed Michel Lagarde to be President and Chief Executive Officer (CEO) and a member of the Company's Board of Directors starting August 31, 2026. He succeeds Eric M. Green, who will retire from his roles as President, CEO and Board Chair on that date. The Company also announced as part of the CEO transition that the Board","category":"company","datetime":1780345800,"headline":"West Appoints Michel Lagarde to be President and Chief Executive Officer"}, {"id":140491518,"url":"https://finnhub.io/api/news?id=7715f06b028c15cfd0883880f5b5e8dad289dc73ae18c028eb2f9cb92e48a24d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"Natera teams with Diakonos to use Signatera MRD testing in a refractory melanoma immunotherapy trial, tracking ctDNA to gauge response.","category":"company","datetime":1780333740,"headline":"NTRA & Diakonos Partner to Use Signatera in Refractory Melanoma Trial"}, {"id":140489989,"url":"https://finnhub.io/api/news?id=e649264ac6f1ebea014950bc3449f38702dbd354f0df843c534f41a0575176cb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"PACB expands HiFi sequencing reach with commercial availability of SPRQ-Nx for Revio, lowering costs by about 30% and adding AI and epigenetics upgrades.","category":"company","datetime":1780326540,"headline":"PacBio Expands HiFi Sequencing Reach With New SPRQ-Nx Technology"}, {"id":140460561,"url":"https://finnhub.io/api/news?id=0ef0d13582f6e663c993edb199983b88a63a47887e5be779decc929f915ac6f6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1780068609,"headline":"Align Technology (ALGN) Down 1.6% Since Last Earnings Report: Can It Rebound?"}, {"id":140458485,"url":"https://finnhub.io/api/news?id=1d30f9f4e86ac10b9f4bdca2646a378a6ae9378669f7df09ed5ee2559dfca4ec","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"HQY tops Q1 FY27 EPS and revenue estimates as HSA accounts and assets climb, and guidance for FY27 revenues and adjusted EPS rises.","category":"company","datetime":1780066380,"headline":"HealthEquity Stock Gains as Q1 Earnings Top Estimates, Revenues Up Y/Y"}, {"id":140472968,"url":"https://finnhub.io/api/news?id=5f623e429ab8bc5a165e7152e24bad61c4766ce54d4666f4e16801a3d6a71d1b","image":"","source":"Benzinga","related":"WST","summary":"Morgan Stanley analyst Kallum Titchmarsh maintains West Pharmaceutical Servs (NYSE:WST) with a Equal-Weight and raises the price target from $315 to $325.","category":"company","datetime":1780054716,"headline":"Morgan Stanley Maintains Equal-Weight on West Pharmaceutical Servs, Raises Price Target to $325"}, {"id":140445072,"url":"https://finnhub.io/api/news?id=a610351807a30d758989a994c957be2f59fd06adcff19aa361bed18654dc9cf1","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"NTRA upgrades Panorama NIPT with SNP-informed deep sequencing, validated for low fetal fraction to cut no-calls and boost reliable prenatal results.","category":"company","datetime":1779980640,"headline":"Natera to Launch Enhanced Panorama NIPT for Low Fetal Fractions"}, {"id":140434912,"url":"https://finnhub.io/api/news?id=d9fc06c8f2e87143c3bd984ab63c962cb2d9d9cccb5d506baed6d920936710bc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"SYK launches Pangea Plating System in Europe, completing its first London case as it broadens trauma care solutions for many fractures.","category":"company","datetime":1779896340,"headline":"Stryker Launches Pangea Plating System in Europe for Fracture Fixation"}, {"id":140431511,"url":"https://finnhub.io/api/news?id=4f51e0755e4c6462f6df6804c20c6e71683e99076fdc3e862f826a60fbf02c75","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2209914068/image_2209914068.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"WST","summary":"The Dividend Aristocrats underperformed SPY YTD, returning 3.34% versus SPY's 10.39%, though 22 Aristocrats still posted double-digit gains.","category":"company","datetime":1779871416,"headline":"Best Dividend Aristocrats: May 2026"}, {"id":140422922,"url":"https://finnhub.io/api/news?id=5185a872bf28645d0a7740203e50cac87714254764a449d0f918e4be669e014e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"BTSG leans on surging Specialty & Infusion and integrated home health branches, but IRA and generic shifts may pressure 2026 margins.","category":"company","datetime":1779811260,"headline":"Here's Why You Should Add BrightSpring Stock to Your Portfolio Now"}, {"id":140421417,"url":"https://finnhub.io/api/news?id=5ca179be283cc52ac0e6856cef034e9d934e587c57061800a0dccdc9427c4550","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"NTRA is expanding in Austin with what it says will be the world's largest sequencing capacity as oncology testing demand keeps surging.","category":"company","datetime":1779807480,"headline":"Natera Expands Austin Operations With New Sequencing Facility"}, {"id":140426213,"url":"https://finnhub.io/api/news?id=c7d1b6130c115637825b03cab5b8f2e0e7f4ad064d8236f45329a4d095cf0f3d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"West Pharmaceutical Services has considerably outperformed the broader market over the past 52 weeks, and Wall Street analysts maintain a highly optimistic outlook about the stock’s prospects.","category":"company","datetime":1779806505,"headline":"Is Wall Street Bullish or Bearish on West Pharmaceutical Services Stock?"}, {"id":140414650,"url":"https://finnhub.io/api/news?id=95eeed52920380b649977145a2d60a7c800c2b061161a4e95fdf5c0ed7b99572","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"Recent performance snapshot West Pharmaceutical Services (WST) has drawn investor attention after a period of solid share performance, with the stock roughly flat over the past day but higher over the past week, month and past 3 months. At a recent close of US$316.42, West Pharmaceutical Services sits on a market value of about US$22.35b, alongside reported annual revenue of US$3.22b and net income of US$542.7m from its injectable drug packaging and delivery business. See our latest analysis...","category":"company","datetime":1779743540,"headline":"A Look At West Pharmaceutical Services (WST) Valuation After Recent Share Price Momentum"}, {"id":140412105,"url":"https://finnhub.io/api/news?id=c36321df2f45eca41091edb2445050975192f64b9534f980847b0c1917ac81ec","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WST","summary":"GEHC teams with UW Medicine Radiology to advance CT and molecular imaging, aiming to automate workflows and speed next-gen imaging to clinics.","category":"company","datetime":1779721140,"headline":"GE HealthCare and UW Medicine Radiology Expand CT, MI Research Tie"}, {"id":140397434,"url":"https://finnhub.io/api/news?id=d7fd9fa7df3d8cb9e54856fe4a536db2d6b33b5b6e8ca948866e0cfb7e6df209","image":"https://www.chartmill.com/images/uploads/minervini_news_8825971f4b.webp","source":"ChartMill","related":"WST","summary":"West Pharmaceutical Services (WST) passes the Minervini Trend Template with perfect moving average alignment and strong relative strength, combined with accelerating 46.9% EPS growth and 21% revenue growth, making it a high-momentum growth stock to watch.","category":"company","datetime":1779537636,"headline":"West Pharmaceutical Services (NYSE:WST) Shows Explosive Potential with Perfect Minervini Trend Template and Accelerating Growth"}
data_source finnhub_news_keyword_model
article_count 8
negative_hits 0
positive_hits 4
recomputed_at_score true
sentiment_score_raw 1.2
source_article_count 75
discarded_article_count 64
sentimentPoints 6

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 3.2 5/110 64% 3.2
資金流 5.2 20/110 26% 5.2
市場環境 9.2 15/110 61.33% 9.2
催化劑 2 20/110 10% 2
風險管理 5.7 10/110 57% 5.7
技術信號 11 30/110 36.67% 11
情緒分析 6 10/110 60% 6

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 4/50
ret_5d -0.0611
max_score 50
max_total 50
raw_total 4
vcp_bonus 0
vol_ratio 0.9935
ret_points 0
vol_points 0
range_ratio 0.8982
volat_points 0
day_range_pct 0.0297
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 0
partial_history false
pullback_points 4
breakout_vol_bonus 0
first_breakout_20d false
return_window_days 5
first_breakout_bonus 0
breakout_quality_points 0

Risk management

level Elevated
reason risk management score >= 5/10

position

score 1.1

details

atrPct 4.0987
turnoverUsdM 216.411
liquidityPoints 0.4
volatilityPoints 0.7
rrPoints 1.4

stopLevels

symbol US.WST
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 213.5786

strength_details

ma_score 1
atr_score 1
rsi_score 2.5
macd_score 1
volume_score 1
market_adjustment 1
risk_reward_ratio 1
stop_loss_percent 8.2
take_profit_price 245.8728
target_multiplier 1.6
technical_strength 1.3
take_profit_percent 5.7
positionPoints 1.1
stopLossPoints 1.2

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 8.1975
diversificationPoints 2

Calculation audit log

基本面分析總分: 3.2/5分
資金流分析總分: 5.2/20分
市場環境分析總分: 9.2/15分
催化劑分析: 2/20分
風險管理總分: 5.7/10分
技術信號分析總分: 11/30分
情緒分析: 6/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 78.57
atr
atr 9.5357
rule ATR / current price; lower volatility scores higher
score 4
atr_pct 4.1
cci
rule Cursor_18.24 CCI bands
level 超買或超賣風險
score 2
value -130.65
cmf
rule Cursor_18.24 CMF bands
level 派發
score 2
value -0.0355
kdj
d 14.99
j 6.7
k 12.22
rule Cursor_18.24 K/D cross
score 0
signal 死叉
mfi
rule Cursor_18.24 MFI bands
level 超賣或超買風險
score 2
value 35.76
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 2
trend 資金流出
value -12646000
recentSlope -595160
previousSlope 231370
rsi
value 22.39
sar
rule Cursor_18.24 Parabolic SAR
score 4
trend 下降
value 269.1886
position SAR喺價上
distancePct 15.71
previousTrend 下降
ma50
value 267.9744
macd
macd -10.0354
trend 看跌
signal -6.311
histogram -3.7243
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 2
value 258.6034
position <VWAP
consecutiveAbove 0
volume
rule Cursor_18.24 volume ratio
level 無力
ratio 0.96
score 4
avgVolume 964920
currentVolume 930200
derived
ma20 262.004
ma50 267.9744
prevClose 235.89
avgVolume10 1249830
avgVolume20 964920
changePercent -1.37
avgVolumeForScore 964920
ma_cross
ma20 262.004
ma50 267.9744
rule Cursor_18.24 MA20/MA50 cross
cross 熊勢
score 0
prevMa20 264.215
prevMa50 268.5486
spreadPct 2.23
isVolumeBreakout false
bollinger
lower 227.955
upper 296.053
position 中間
rsi_short
value 14.82
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 0.96

Raw calculation JSON

 
{
  "risk": {
    "level": "Elevated",
    "reason": "risk management score >= 5/10",
    "position": {
      "score": 1.1,
      "details": {
        "atrPct": 4.098732177035554,
        "turnoverUsdM": 216.41102069800002,
        "liquidityPoints": 0.4,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.WST",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 213.5786,
      "strength_details": {
        "ma_score": 1,
        "atr_score": 1,
        "rsi_score": 2.5,
        "macd_score": 1,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 8.2,
      "take_profit_price": 245.8728,
      "target_multiplier": 1.6,
      "technical_strength": 1.3,
      "take_profit_percent": 5.7
    },
    "positionPoints": 1.1,
    "stopLossPoints": 1.2,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 8.197464354071109,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 46.3,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 42.3,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 4
  },
  "market": {
    "ma20": 262.004,
    "ma50": 267.9744,
    "close": 232.65,
    "prevClose": 235.89,
    "avgVolume20": 964920,
    "volumeRatio": 0.96,
    "changePercent": -1.37
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred+database-backfill-market-proxy"
  },
  "barCount": 152,
  "momentum": {
    "max": 50,
    "result": 4,
    "details": {
      "ret_5d": -0.06106227298409883,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 4,
      "vcp_bonus": 0,
      "vol_ratio": 0.9935486627360506,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 0.8981644819497139,
      "volat_points": 0,
      "day_range_pct": 0.029744252299344676,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 4,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 46.3,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.2,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 64,
        "contribution": 3.2
      },
      {
        "raw": 5.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 26,
        "contribution": 5.2
      },
      {
        "raw": 9.2,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 61.33,
        "contribution": 9.2
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 5.7,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 57,
        "contribution": 5.7
      },
      {
        "raw": 11,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 36.67,
        "contribution": 11
      },
      {
        "raw": 6,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 60,
        "contribution": 6
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 42.3,
    "details": [
      "基本面分析總分: 3.2/5分",
      "資金流分析總分: 5.2/20分",
      "市場環境分析總分: 9.2/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 5.7/10分",
      "技術信號分析總分: 11/30分",
      "情緒分析: 6/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.2,
      "資金流": 5.2,
      "市場環境": 9.2,
      "情緒分析": 6,
      "技術信號": 11,
      "風險管理": 5.7
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "一般",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0.6,
          "debtPoints": 0.5,
          "marginPoints": 0.4,
          "turnoverUsdM": 216.41102069800002,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 0.8,
          "obvPoints": 0.8,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.WST",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred+database-backfill-market-proxy",
              "vixClose": 16.88
            }
          },
          "trend": {
            "score": 4,
            "details": {
              "qqq": {
                "ma20": 122.61478269900859,
                "ma50": 120.33679393046637,
                "name": "QQQ",
                "close": 123.60451782236825,
                "points": 2
              },
              "spy": {
                "ma20": 113.55381417366178,
                "ma50": 111.1755451350621,
                "name": "SPY",
                "close": 114.16020903227539,
                "points": 2
              },
              "source": "twelvedata+fred+database-backfill-market-proxy"
            }
          },
          "atrPct": 4.098732177035554,
          "atrPoints": 2,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "一般",
        "items": {
          "sentiment": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 4,
              "sentimentScoreRaw": 1.2
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 140686517,
                "url": "https://finnhub.io/api/news?id=c45fa16b883b56b09f51b1545b23e20502ab16065766ea6582c6474cef1bcaaf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services (WST) stock has drawn attention after recent share price moves, with investors weighing its role in drug containment and delivery in relation to current valuation signals and recent returns over the past month and past 3 months. See our latest analysis for West Pharmaceutical Services. At a share price of $327.95, West Pharmaceutical Services has seen strong momentum build over the past quarter, with a 35.85% 3 month share price return and a 52.46% 1 year total...",
                "category": "company",
                "datetime": 1782065240,
                "headline": "West Pharmaceutical Services (WST) Stock Could Be 6.9% Undervalued on GLP 1 Growth Narrative"
              },
              {
                "id": 140641821,
                "url": "https://finnhub.io/api/news?id=2bcf0b980697bdd68bd35d50bc5c863ee6dd8914bd2951100d61af11d76c6ed7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services recently reported strong first-quarter 2026 results, highlighting robust growth in biologics-related high-value components and self-injection delivery devices, and raised its full-year 2026 revenue and adjusted EPS guidance. The company emphasized its role as a critical part of injectable-drug infrastructure rather than a conventional packaging supplier, underlining how its specialized high-value products support complex biologic therapies. Next, we’ll examine...",
                "category": "company",
                "datetime": 1781572160,
                "headline": "How Investors May Respond To West Pharmaceutical Services (WST) Upgraded 2026 Outlook And Biologics Momentum"
              },
              {
                "id": 140588081,
                "url": "https://finnhub.io/api/news?id=f2cf94bb03b8b2b5e729f6d1843e2f16c0cdf55e30b710fb5426d2240c9c7cc8",
                "image": "",
                "source": "Fintel",
                "related": "WST",
                "summary": "",
                "category": "company",
                "datetime": 1781047666,
                "headline": "Barclays Upgrades West Pharmaceutical Services (WST)"
              },
              {
                "id": 140595179,
                "url": "https://finnhub.io/api/news?id=562c9de279ec4933fe1d981ae426245f1dfc1fafd419982c3aaf1d713c6bfd6d",
                "image": "https://image.cnbcfm.com/api/v1/image/108319218-17810424221781042420-46447529485-1080pnbcnews.jpg?v=1781042422&w=1920&h=1080",
                "source": "CNBC",
                "related": "WST",
                "summary": "The final trades of the day with CNBC's Melissa Lee and the 'Fast Money' traders.",
                "category": "company",
                "datetime": 1781028187,
                "headline": "Final Trade: WST, URI, SMH, MCD"
              },
              {
                "id": 140577352,
                "url": "https://finnhub.io/api/news?id=f0807d13a6f900cfc94a56be7ed5f28a34388820525ad4087e3c8f5e2c4cbaf9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "With a net profit margin of 16.85%, West Pharmaceutical Services, Inc. (NYSE:WST) is included among the 10 Most Profitable Dividend Stocks to Invest In Now. Wolfe Research analyst Mike Polark upgraded West Pharmaceutical Services, Inc. (NYSE:WST) to Outperform from Peer Perform on June 2. He also assigned a $375 price target to the stock. The analyst […]",
                "category": "company",
                "datetime": 1780976158,
                "headline": "Wolfe Research Says West Pharmaceutical Services (WST) is Positioned to Benefit from Injectable Drug Growth"
              },
              {
                "id": 140560483,
                "url": "https://finnhub.io/api/news?id=213465d7d38c064deb83e491ca79c6de5df36e0ae864720233ae4bdbe2274a7b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services Inc (NYSE:WST) is one of the best stocks to buy according to billionaire Bill Gates. WST stock is up around 14% year-to-date and has gained nearly 50% over the past year. Analysts still see upside potential in the stock. On May 31, Wolfe Research initiated coverage of West Pharmaceutical Services Inc (NYSE:WST) […]",
                "category": "company",
                "datetime": 1780854489,
                "headline": "Wolfe Research Weighs on West Pharmaceutical Services Inc (WST) Stock"
              },
              {
                "id": 140560484,
                "url": "https://finnhub.io/api/news?id=624aaed2b48741460274ab9dc9e8612a0c2934308a5b072f9187cbcdc1b01cd8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "The updated analyst narrative for West Pharmaceutical Services now reflects a fair value estimate of US$352.36 per share, up from US$349.85. This refinement sits alongside fresh company guidance for Q2 2026 net sales, a recent buyback of 1,222,019 shares for US$297.65 million, and an announced leadership transition planned for the second half of 2026. Read on to see how these moving parts fit together and how you can keep track of the evolving story. Wall Street's queuing for one rocket...",
                "category": "company",
                "datetime": 1780851992,
                "headline": "How The West Pharmaceutical Services (WST) Story Is Evolving With Guidance Buybacks And New Leadership"
              },
              {
                "id": 140520222,
                "url": "https://finnhub.io/api/news?id=ce828ac4c9c92407eae58dd8869c1d76da721bf6460f19af62789834939ff7c6",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "WST",
                "summary": "2026-06-04. The following slide deck was published by West Pharmaceutical Services, Inc.",
                "category": "company",
                "datetime": 1780542088,
                "headline": "West Pharmaceutical Services, Inc. (WST) Presents at 46th Annual William Blair Growth Stock Conference - Slideshow"
              }
            ],
            "raw_source": [
              {
                "id": 140686517,
                "url": "https://finnhub.io/api/news?id=c45fa16b883b56b09f51b1545b23e20502ab16065766ea6582c6474cef1bcaaf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services (WST) stock has drawn attention after recent share price moves, with investors weighing its role in drug containment and delivery in relation to current valuation signals and recent returns over the past month and past 3 months. See our latest analysis for West Pharmaceutical Services. At a share price of $327.95, West Pharmaceutical Services has seen strong momentum build over the past quarter, with a 35.85% 3 month share price return and a 52.46% 1 year total...",
                "category": "company",
                "datetime": 1782065240,
                "headline": "West Pharmaceutical Services (WST) Stock Could Be 6.9% Undervalued on GLP 1 Growth Narrative"
              },
              {
                "id": 140670839,
                "url": "https://finnhub.io/api/news?id=67b3a881297b7772c29c5238e360566a31094107768093e0f084d29a29891adf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "TXG collaborates with the Cleveland Clinic to advance bladder cancer diagnostics using Flex Apex, Xenium and potentially Atera.",
                "category": "company",
                "datetime": 1781879460,
                "headline": "10x Genomics, Cleveland Clinic Team Up on Bladder Cancer Diagnostics"
              },
              {
                "id": 140670840,
                "url": "https://finnhub.io/api/news?id=c6a7812f159ccb5aaef45ee570ae7d8e2b9f14fd8e26006ea81049dde42451b5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "BAX gains as Synovis MCA signs a multi-year deal to commercialize MediThinQ's SHIYA 3D surgical visualization platform worldwide.",
                "category": "company",
                "datetime": 1781878980,
                "headline": "Baxter's Unit Synovis MCA to Lead Global Rollout of the SHIYA Platform"
              },
              {
                "id": 140670077,
                "url": "https://finnhub.io/api/news?id=77483a1986c2444fbad0d762dfd0ec0e9346104b5c753aa6dfc4083fdbd21d63",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Cardinal Health has gained nearly 8% in 2026 as specialty pharma growth, rising EPS, and expanding healthcare services fuel investor optimism.",
                "category": "company",
                "datetime": 1781872560,
                "headline": "CAH Stock Up Nearly 8% YTD: Will the Uptrend Continue in the Rest of 2026?"
              },
              {
                "id": 140664196,
                "url": "https://finnhub.io/api/news?id=44be2be72418cae135bcebd527ed2c7099c025f77f83a5ccac5939b911f80b2b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "COR shares are down 18% YTD, but rising EPS guidance, specialty pharma growth and strategic expansion could make this pullback worth watching.",
                "category": "company",
                "datetime": 1781801340,
                "headline": "COR Stock Down Nearly 18% YTD: Should You Buy, Hold or Sell?"
              },
              {
                "id": 140663236,
                "url": "https://finnhub.io/api/news?id=54c47bc52510c4e70318b2b62ce1fb07e7599da324ff0847e8fd38a8edc0e03c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "COR's enhanced Nucleus platform targets complex specialty medication workflows, with a pilot underway across more than 20 physician practice sites.",
                "category": "company",
                "datetime": 1781793180,
                "headline": "Cencora Launches Enhanced Nucleus Solution for Specialty Practices"
              },
              {
                "id": 140663276,
                "url": "https://finnhub.io/api/news?id=9c6bc3e6685dd167ee737b80671b69ce4b3fbf27f24e0fe6e1772a57ac74527f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "AngioDynamics' FDA IDE approval for RELIEF advances NanoKnife IRE study as a potential minimally invasive BPH treatment.",
                "category": "company",
                "datetime": 1781790720,
                "headline": "ANGO Gains FDA IDE Approval for NanoKnife BPH Feasibility Study"
              },
              {
                "id": 140655101,
                "url": "https://finnhub.io/api/news?id=c6820df331bb939fd0a563fc99c4f276fe5209059cfa807223eeb2aba2ebe109",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "QDEL's strong portfolio, cost-saving progress and mixed first-quarter results support growth, though respiratory reliance remains a risk.",
                "category": "company",
                "datetime": 1781709360,
                "headline": "Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now"
              },
              {
                "id": 140653696,
                "url": "https://finnhub.io/api/news?id=25acde4485ef5b4d91cc6eefe2ef7f92cb071df76329d0ed90613b00e4ce091e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "LIVN's PolySync data show an 84.5% AHI response rate in OSA patients, building on OSPREY results for its aura6000 System.",
                "category": "company",
                "datetime": 1781705640,
                "headline": "LivaNova Reports Improved OSA Outcomes With PolySync Programming"
              },
              {
                "id": 140648039,
                "url": "https://finnhub.io/api/news?id=15d6a6da3b9d3800527810852b9cb36443de1cbe24001fad935a1b3e373c974f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "BAX is pursuing a broad turnaround as innovation, resilient demand, and AI integration support recovery despite regulatory risks and margin pressure.",
                "category": "company",
                "datetime": 1781633640,
                "headline": "Reasons to Retain Baxter International Stock in Your Portfolio for Now"
              },
              {
                "id": 140647069,
                "url": "https://finnhub.io/api/news?id=57f1f61b15e61892ad7b0d9677ac4ee53002c5b993308bacb0aeace1d83807f9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "NSPR's positive CGUARDIANS II data show 100% acute device success, supporting a potential FDA approval for CGuard Prime TCAR in late 2026.",
                "category": "company",
                "datetime": 1781628060,
                "headline": "InspireMD Posts Positive CGUARDIANS II Data for CGuard Prime TCAR"
              },
              {
                "id": 140645762,
                "url": "https://finnhub.io/api/news?id=a8d63b72d303e6561b81214e4faddf0c3ad8576ea34cddd328f137ea21e8e67d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "DexCom's FDA-cleared Stelo OTC glucose biosensor now covers children aged above 2 years not using insulin, expanding access to smartphone-linked CGM insights.",
                "category": "company",
                "datetime": 1781618100,
                "headline": "DXCM Receives FDA Clearance for Stelo OTC CGM System for Children"
              },
              {
                "id": 140645722,
                "url": "https://finnhub.io/api/news?id=8609db04e140777425e1b39bcadd535acf2b839741f5f4815bf0bf3fcc060be3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Becton, Dickinson's MedTech focus, innovation push and strategic partnerships support growth optimism, though reimbursement uncertainty remains a key concern.",
                "category": "company",
                "datetime": 1781618040,
                "headline": "Here's Why You Should Retain BDX Stock in Your Portfolio Now"
              },
              {
                "id": 140641821,
                "url": "https://finnhub.io/api/news?id=2bcf0b980697bdd68bd35d50bc5c863ee6dd8914bd2951100d61af11d76c6ed7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services recently reported strong first-quarter 2026 results, highlighting robust growth in biologics-related high-value components and self-injection delivery devices, and raised its full-year 2026 revenue and adjusted EPS guidance. The company emphasized its role as a critical part of injectable-drug infrastructure rather than a conventional packaging supplier, underlining how its specialized high-value products support complex biologic therapies. Next, we’ll examine...",
                "category": "company",
                "datetime": 1781572160,
                "headline": "How Investors May Respond To West Pharmaceutical Services (WST) Upgraded 2026 Outlook And Biologics Momentum"
              },
              {
                "id": 140639070,
                "url": "https://finnhub.io/api/news?id=f5600064373a72432725385186e30bfca82b04dc591c663e50d057d4052fd67a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "QGEN's QIAcuity expansion adds gene expression assays, multiplexing, automation and analysis tools to drive dPCR adoption.",
                "category": "company",
                "datetime": 1781536560,
                "headline": "QIAGEN Expands QIAcuity Gene Expression Portfolio to Drive dPCR Use"
              },
              {
                "id": 140638230,
                "url": "https://finnhub.io/api/news?id=64cb42c51cfc3a9a64d381a8a82b83a57307d72c071ebeff543fedd59840459c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "GE HealthCare expands its Carilion Clinic collaboration with AAMP and Encompass to improve equipment management and operational efficiency across Virginia.",
                "category": "company",
                "datetime": 1781535000,
                "headline": "GEHC Expands Carilion Tie to Enhance Patient Care Across Virginia"
              },
              {
                "id": 140637328,
                "url": "https://finnhub.io/api/news?id=47736f5137f3207a02d96c00e27f877870297de1fbe90a74ad6d1cca3d437c30",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical continues to outpace broader market gains on strong earnings momentum and supportive analyst sentiment.",
                "category": "company",
                "datetime": 1781506536,
                "headline": "Is West Pharmaceutical Stock Outperforming the S&P 500?"
              },
              {
                "id": 140621746,
                "url": "https://finnhub.io/api/news?id=d41d25da43b74e3068e20e63e981f5de87afdbf670dc0272d399431273931bb8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Stryker faces cyberattack fallout, but strong procedure demand, record Mako adoption and global expansion continue to support long-term growth.",
                "category": "company",
                "datetime": 1781284560,
                "headline": "Here's Why You Should Hold Stryker Stock in Your Portfolio for Now"
              },
              {
                "id": 140620400,
                "url": "https://finnhub.io/api/news?id=75037c34a442a251bd2fc892e46eae16ae7cd126e4828d381b146e8aa3035172",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "VEEV's UCB pharmacovigilance deal expands Safety Suite adoption, supporting automation, compliance and long-term growth opportunities.",
                "category": "company",
                "datetime": 1781276940,
                "headline": "Veeva Expands Safety Suite Footprint With UCB Pharmacovigilance Deal"
              },
              {
                "id": 140620404,
                "url": "https://finnhub.io/api/news?id=e98d9a5f89955a1d56754c58dff390c94641534b95b0427387b54b37a4bcaebf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "HQY benefits from strong HSA growth, AI-driven automation and solid first-quarter fiscal 2027 results despite data security risks.",
                "category": "company",
                "datetime": 1781276760,
                "headline": "Reasons to Hold HealthEquity Stock in Your Portfolio for Now"
              },
              {
                "id": 140618921,
                "url": "https://finnhub.io/api/news?id=e08c22750b7d6f78f92d4852e6c3f42d1c475c88ab2cf11a25aa7305ede35077",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "OGN's TOFIDENCE gains FDA approval for life-threatening CRS and certain hospitalized COVID-19 patients, broadening its critical-care role.",
                "category": "company",
                "datetime": 1781270100,
                "headline": "Organon Wins FDA Nod to Expand TOFIDENCE Use in Severe CRS & COVID-19"
              },
              {
                "id": 140609317,
                "url": "https://finnhub.io/api/news?id=0b61c1b7cd82674e2b54e6af7d021d35169efb1e197b734b68dc4aac8899296d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "SENS partners with Welldoc on a next-gen Eversense 365 app, adding Apple Health/Google Health Connect integration ahead of the U.S. launch.",
                "category": "company",
                "datetime": 1781197560,
                "headline": "Senseonics Expands Eversense 365 Ecosystem With Welldoc Partnership"
              },
              {
                "id": 140607396,
                "url": "https://finnhub.io/api/news?id=4eb12ea0b2496c6afcfb326c0e00e56e23f3b85b409353f4e1061c29fa273987",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "HNGE expands HingeSelect to include orthopedic surgery, aiming to deliver coordinated end-to-end MSK care from imaging to post-op recovery.",
                "category": "company",
                "datetime": 1781187540,
                "headline": "Hinge Health Expands HingeSelect to Offer End-to-End MSK Surgical Care"
              },
              {
                "id": 140597695,
                "url": "https://finnhub.io/api/news?id=04be83266d4dc472ff2093bf24f6d86adf2e21af82f8afadd1a6cf0cb580fada",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "10x Genomics stock rises after acquiring Proteintech Genomics, adding high-plex proteomics tools that strengthen multiomics research and support platform adoption.",
                "category": "company",
                "datetime": 1781111040,
                "headline": "TXG Gains From Proteintech Deal, Expands Multiomics Capabilities"
              },
              {
                "id": 140596135,
                "url": "https://finnhub.io/api/news?id=be1d78fa564e9e85530462a79e73bf9a0d945cb4a049ea9a7a45c5d52edd8399",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "VEEV's strong Q1, growing Vault CRM migrations and AI expansion support growth, though life sciences CRM market saturation poses risks.",
                "category": "company",
                "datetime": 1781110740,
                "headline": "Reasons to Add Veeva Systems Stock to Your Portfolio for Now"
              },
              {
                "id": 140594177,
                "url": "https://finnhub.io/api/news?id=394e401e88c6fe79926058b87ac0b55d27ac77c7d00c881953ecdb67150362b8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "NPCE rides strong RNS adoption and AI tools nearing FDA review, with a mid-2026 IGE decision offering upside despite near-term losses.",
                "category": "company",
                "datetime": 1781102280,
                "headline": "Here's Why You Should Add NeuroPace Stock to Your Portfolio Now"
              },
              {
                "id": 140594178,
                "url": "https://finnhub.io/api/news?id=a32b20b8fcb710eee7fb6d1d490938674b31a2b22daa764fb9412dcf6f4f75c8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "AMN Healthcare acquires Jaide Health to add AI-powered interpretation and translation, widening language access across more healthcare touchpoints.",
                "category": "company",
                "datetime": 1781102160,
                "headline": "AMN Expands Language Services Portfolio With Jaide Health Deal"
              },
              {
                "id": 140588081,
                "url": "https://finnhub.io/api/news?id=f2cf94bb03b8b2b5e729f6d1843e2f16c0cdf55e30b710fb5426d2240c9c7cc8",
                "image": "",
                "source": "Fintel",
                "related": "WST",
                "summary": "",
                "category": "company",
                "datetime": 1781047666,
                "headline": "Barclays Upgrades West Pharmaceutical Services (WST)"
              },
              {
                "id": 140589643,
                "url": "https://finnhub.io/api/news?id=bcc959a3c7e1e0be16f14bc6c45755af87a23723537381f05dd09eb76f7a7ffd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -0.26%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.17%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.12%. June E-mini S&P futures (ESM26 ) fell -0.36%, and June E-mini Nasdaq futures...",
                "category": "company",
                "datetime": 1781037276,
                "headline": "Broader Market Settles Lower as Chip Stocks Sink"
              },
              {
                "id": 140584417,
                "url": "https://finnhub.io/api/news?id=5d919263361adc34d9b2d860affbcd2effa99ebafb7d49fc3e9a84863a15bd74",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "WST",
                "summary": "Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.",
                "category": "company",
                "datetime": 1781031900,
                "headline": "Top S&P500 movers in Tuesday's session"
              },
              {
                "id": 140595179,
                "url": "https://finnhub.io/api/news?id=562c9de279ec4933fe1d981ae426245f1dfc1fafd419982c3aaf1d713c6bfd6d",
                "image": "https://image.cnbcfm.com/api/v1/image/108319218-17810424221781042420-46447529485-1080pnbcnews.jpg?v=1781042422&w=1920&h=1080",
                "source": "CNBC",
                "related": "WST",
                "summary": "The final trades of the day with CNBC's Melissa Lee and the 'Fast Money' traders.",
                "category": "company",
                "datetime": 1781028187,
                "headline": "Final Trade: WST, URI, SMH, MCD"
              },
              {
                "id": 140586782,
                "url": "https://finnhub.io/api/news?id=013c492ea1177f0c3f9567fa2d3922db467343d1a94cb1300e7ea4dd4369a0cc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "The S&P 500 Index ($SPX ) (SPY ) today is down -0.28%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.80%. June E-mini S&P futures (ESM26 ) are down -0.25%, and June E-mini Nasdaq futures...",
                "category": "company",
                "datetime": 1781018614,
                "headline": "Stocks Erase Early Gains as Chipmakers Turn Lower"
              },
              {
                "id": 140585270,
                "url": "https://finnhub.io/api/news?id=071e4439ba6f7c7a02031814c060678dbc089041f0a1d66d87162879ad1639e0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "The S&P 500 Index ($SPX ) (SPY ) today is up +0.93%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.89%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.17%. June E-mini S&P futures (ESM26 ) are up +0.76%, and June E-mini Nasdaq futures...",
                "category": "company",
                "datetime": 1781014097,
                "headline": "Stocks Climb on an AI-Led Rebound"
              },
              {
                "id": 140582299,
                "url": "https://finnhub.io/api/news?id=fb6f13d08b877506eee8ba1556c9c2305e7b73adbdfdf44d203c6b6b2cbdd90b",
                "image": "https://image.cnbcfm.com/api/v1/image/108318920-17810228181781022815-46442812417-1080pnbcnews.jpg?v=1781022817&w=1920&h=1080",
                "source": "CNBC",
                "related": "WST",
                "summary": "The Investment Committee debate the latest Calls of the Day.",
                "category": "company",
                "datetime": 1781008925,
                "headline": "Calls of the Day: Health Care and Materials"
              },
              {
                "id": 140579796,
                "url": "https://finnhub.io/api/news?id=2c80a8780cd086fbb7f801f79dfa446501a8bfc3e5d4da90e8f9330862392242",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "WST",
                "summary": "Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.",
                "category": "company",
                "datetime": 1781008500,
                "headline": "Stay updated with the S&P500 stocks that are on the move in today's pre-market session."
              },
              {
                "id": 140579570,
                "url": "https://finnhub.io/api/news?id=57060f44c3c7608cab5ed0daaed5e30d5abfff1b2239ef0cb781d5059dcb8697",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Pre-Market Stock Futures: Futures are trading higher after the bulls tried to rally stocks on Monday, after the drubbing they took on Friday, and it looks the same way today. While it was a partial victory on Monday, by the close, the huge gains from the morning were cut in half, and the Dow Jones ... Here Are Tuesday’s Top Wall Street Analyst Research Calls: Cerebras Systems, Cleveland-Cliffs, Equity Residential, FuelCell Energy, Lennar, Luckin Coffee, Toll Brothers, and More",
                "category": "company",
                "datetime": 1781006280,
                "headline": "Here Are Tuesday’s Top Wall Street Analyst Research Calls: Cerebras Systems, Cleveland-Cliffs, Equity Residential, FuelCell Energy, Lennar, Luckin Coffee, Toll Brothers, and More"
              },
              {
                "id": 140580749,
                "url": "https://finnhub.io/api/news?id=693d2424a535a5e2af172ea1750a6085618ce14d58c53eb4be46b008fb605916",
                "image": "https://cdn.benzinga.com/files/images/story/2026/06/09/Analyst-Works-On-Personal-Computer-Showi.jpeg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "WST",
                "summary": "Wall Street analysts upgraded AJG &amp; BRC. See analyst rating changes &amp; how they view BRC stock.",
                "category": "company",
                "datetime": 1780998208,
                "headline": "This Brady Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday"
              },
              {
                "id": 140580781,
                "url": "https://finnhub.io/api/news?id=97225e73910a80f9647f6c424811b66a25497906c5a22e0740b3dcc673780e02",
                "image": "",
                "source": "Benzinga",
                "related": "WST",
                "summary": "Barclays  analyst Luke Sergott   upgrades West Pharmaceutical Servs (NYSE:WST) from Equal-Weight to Overweight and raises the price target from $310 to $400.",
                "category": "company",
                "datetime": 1780996242,
                "headline": "Barclays Upgrades West Pharmaceutical Servs to Overweight, Raises Price Target to $400"
              },
              {
                "id": 140577352,
                "url": "https://finnhub.io/api/news?id=f0807d13a6f900cfc94a56be7ed5f28a34388820525ad4087e3c8f5e2c4cbaf9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "With a net profit margin of 16.85%, West Pharmaceutical Services, Inc. (NYSE:WST) is included among the 10 Most Profitable Dividend Stocks to Invest In Now. Wolfe Research analyst Mike Polark upgraded West Pharmaceutical Services, Inc. (NYSE:WST) to Outperform from Peer Perform on June 2. He also assigned a $375 price target to the stock. The analyst […]",
                "category": "company",
                "datetime": 1780976158,
                "headline": "Wolfe Research Says West Pharmaceutical Services (WST) is Positioned to Benefit from Injectable Drug Growth"
              },
              {
                "id": 140572797,
                "url": "https://finnhub.io/api/news?id=f3ae8e0e7ff1289ad266adc145830d785a452d195d081cf0fb84b57585011dfe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "DXCM reports positive CONNECT trial results as Dexcom G7 improves HbA1c and time in range in adults with Type 2 diabetes not using insulin.",
                "category": "company",
                "datetime": 1780939740,
                "headline": "DexCom Reports Positive CONNECT Data for Non-Insulin Diabetes"
              },
              {
                "id": 140571185,
                "url": "https://finnhub.io/api/news?id=6febccff9e92b0b0fc22342b88808621fa97975fcb1725038dae6115ffe0f58c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "MMSI leans on therapeutic strength, an oncology acquisition and a new stent launch, but tariffs, OEM weakness and China pressure shadow 2026.",
                "category": "company",
                "datetime": 1780933920,
                "headline": "Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now"
              },
              {
                "id": 140571186,
                "url": "https://finnhub.io/api/news?id=45634515759aa264e22ecc0b29b417f9dc3d2a7226e764e5b7c1ee84db93aa55",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Natera teams with CytoDyn to track ctDNA in CLOVER Phase 2, using Signatera to map leronlimab response in metastatic colorectal cancer.",
                "category": "company",
                "datetime": 1780933680,
                "headline": "NTRA & CytoDyn Partner to Advance ctDNA-Guided Development in mCRC"
              },
              {
                "id": 140565883,
                "url": "https://finnhub.io/api/news?id=ff7bc405867f5d2d57afcfe438453133658c30769539900c2f89015433e6159e",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2238324635/image_2238324635.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "WST",
                "summary": "A curated universe of 50 high-quality dividend growth stocks identifies attractive entry points based on valuation and forward return potential. Check out the list here.",
                "category": "company",
                "datetime": 1780894271,
                "headline": "Top 50 High-Quality Dividend Growth Stocks For June 2026"
              },
              {
                "id": 140560483,
                "url": "https://finnhub.io/api/news?id=213465d7d38c064deb83e491ca79c6de5df36e0ae864720233ae4bdbe2274a7b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services Inc (NYSE:WST) is one of the best stocks to buy according to billionaire Bill Gates. WST stock is up around 14% year-to-date and has gained nearly 50% over the past year. Analysts still see upside potential in the stock. On May 31, Wolfe Research initiated coverage of West Pharmaceutical Services Inc (NYSE:WST) […]",
                "category": "company",
                "datetime": 1780854489,
                "headline": "Wolfe Research Weighs on West Pharmaceutical Services Inc (WST) Stock"
              },
              {
                "id": 140560484,
                "url": "https://finnhub.io/api/news?id=624aaed2b48741460274ab9dc9e8612a0c2934308a5b072f9187cbcdc1b01cd8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "The updated analyst narrative for West Pharmaceutical Services now reflects a fair value estimate of US$352.36 per share, up from US$349.85. This refinement sits alongside fresh company guidance for Q2 2026 net sales, a recent buyback of 1,222,019 shares for US$297.65 million, and an announced leadership transition planned for the second half of 2026. Read on to see how these moving parts fit together and how you can keep track of the evolving story. Wall Street's queuing for one rocket...",
                "category": "company",
                "datetime": 1780851992,
                "headline": "How The West Pharmaceutical Services (WST) Story Is Evolving With Guidance Buybacks And New Leadership"
              },
              {
                "id": 140538722,
                "url": "https://finnhub.io/api/news?id=ad27267a41303855f19475c950ff3f67fe4301be6b6442dd863342c993648e61",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Cooper Companies beats Q2 EPS and sales estimates as CooperVision and CooperSurgical hit record revenues, even with a GAAP loss from recall litigation.",
                "category": "company",
                "datetime": 1780673880,
                "headline": "COO Stock Rises on Q2 Earnings Beat, FY26 Revenue Guidance Trimmed"
              },
              {
                "id": 140538723,
                "url": "https://finnhub.io/api/news?id=0702798f8e3683b4455d8c179399e7497cb45d75fdd3fca436c501893ff5f49f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Fresenius Medical Care launches kinexus, a home dialysis platform integrating remote monitoring, prescription management and supply ordering for PD and HHD.",
                "category": "company",
                "datetime": 1780673460,
                "headline": "FMS Launches kinexus Digital Platform for Home Dialysis Care"
              },
              {
                "id": 140536761,
                "url": "https://finnhub.io/api/news?id=e2ab2306c3de68e6b7105a7966bc3fe0db0bf058bd4a7d9bed4a6788cbba38a0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "GEHC wins FDA clearance for AI-powered radiation planning software, adding new clinical models and a pathway for faster future updates.",
                "category": "company",
                "datetime": 1780665780,
                "headline": "GE HealthCare Gains FDA Clearance for AI Radiation Planning Software"
              },
              {
                "id": 140527622,
                "url": "https://finnhub.io/api/news?id=c153492ac08ff08c921bb41a0473cad843f2b266789d64fe8c26b060dccf050b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "DXCM banks on CGM market growth, expanding international demand and strong Q1 momentum, though competitive pressures remain a key risk.",
                "category": "company",
                "datetime": 1780596480,
                "headline": "Here's Why You Should Retain DexCom Stock in Your Portfolio"
              },
              {
                "id": 140527625,
                "url": "https://finnhub.io/api/news?id=6c429bc7f54211872429a8f1198ac780e85f8eec452186d15f6f4fdb78425292",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Veeva Systems beats Q1 earnings and revenue estimates, raises fiscal 2027 guidance, and expands AI offerings as adoption of its software platforms expands.",
                "category": "company",
                "datetime": 1780596000,
                "headline": "VEEV Stock Down Despite Q1 Earnings & Revenues Beat Estimates"
              },
              {
                "id": 140525722,
                "url": "https://finnhub.io/api/news?id=56d7fbb3dd9495daa15f3f44eacf5d3bddff04930e3bf2c74e41665b8425264f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.",
                "category": "company",
                "datetime": 1780593930,
                "headline": "3 Profitable Stocks with Open Questions"
              },
              {
                "id": 140525723,
                "url": "https://finnhub.io/api/news?id=3968fbc00a0bf492b7ff276f3804cf730e53ac8055fc1d60d481964975726844",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1780587016,
                "headline": "Why Is Henry Schein (HSIC) Up 4.6% Since Last Earnings Report?"
              },
              {
                "id": 140523690,
                "url": "https://finnhub.io/api/news?id=06d9bb0ed8a12e7287c2c0622182292e3b4f634cb45e1043cf11ca1cd7115b82",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "SYK launches TPX HD, a small bone power tool built for complex revisions, MIS and oral maxillofacial cases with higher torque and speed.",
                "category": "company",
                "datetime": 1780582980,
                "headline": "Stryker Launches TPX HD Power Tool for Complex Orthopedic Procedures"
              },
              {
                "id": 140520222,
                "url": "https://finnhub.io/api/news?id=ce828ac4c9c92407eae58dd8869c1d76da721bf6460f19af62789834939ff7c6",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "WST",
                "summary": "2026-06-04. The following slide deck was published by West Pharmaceutical Services, Inc.",
                "category": "company",
                "datetime": 1780542088,
                "headline": "West Pharmaceutical Services, Inc. (WST) Presents at 46th Annual William Blair Growth Stock Conference - Slideshow"
              },
              {
                "id": 140516318,
                "url": "https://finnhub.io/api/news?id=4b62cb593bd59e32a2483bdaeb8f4ba062a24ab09d80deb1aebc46a949d0d2b7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "PACB's growth is supported by HiFi sequencing advances and product momentum, though funding pressures weigh on instrument demand.",
                "category": "company",
                "datetime": 1780508580,
                "headline": "Here's Why You Should Add PacBio Stock to Your Portfolio Now"
              },
              {
                "id": 140507158,
                "url": "https://finnhub.io/api/news?id=acd00d192216777c2800d6a0f12795cdc6c11830248f8dc52168f3554c9c1c40",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "WST",
                "summary": "West Pharmaceutical Services, Inc. (WST) 46th Annual William Blair Growth Stock Conference June 2, 2026 5:00 PM EDTCompany ParticipantsEric Green -...",
                "category": "company",
                "datetime": 1780427513,
                "headline": "West Pharmaceutical Services, Inc. (WST) Presents at 46th Annual William Blair Growth Stock Conference Prepared Remarks Transcript"
              },
              {
                "id": 140502662,
                "url": "https://finnhub.io/api/news?id=ddf6e8145494fe589a6f7cfb39965e2d8b318dff95a9437a33546d81f2fcbc2e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "AMN Healthcare is riding MSP momentum, labor disruption demand and AI platforms, yet faces pricing pressure and post-disruption volatility.",
                "category": "company",
                "datetime": 1780415940,
                "headline": "Here's Why You Should Retain AMN Stock in Your Portfolio for Now"
              },
              {
                "id": 140502663,
                "url": "https://finnhub.io/api/news?id=74d8edf2de013e3d5a091c45a81f7a890cad8dc2cc24eb5445cec5a0de77a4a2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "NeuroPace wins FDA OK for ECoG Assistant, its first AI feature for epilepsy care, leveraging RNS EEG data to speed ECoG review and insights.",
                "category": "company",
                "datetime": 1780415400,
                "headline": "NPCE Receives FDA Approval for AI-Powered ECoG Assistant for Epilepsy"
              },
              {
                "id": 140502246,
                "url": "https://finnhub.io/api/news?id=e636a17a5c506931403f8c9acd0bb62ac776b085fc858f38332091ccdadafe37",
                "image": "",
                "source": "Benzinga",
                "related": "WST",
                "summary": "Stephens &amp; Co.  analyst Steven Etoch   reiterates West Pharmaceutical Servs (NYSE:WST) with a Overweight and maintains $360 price target.",
                "category": "company",
                "datetime": 1780390097,
                "headline": "Stephens & Co. Reiterates Overweight on West Pharmaceutical Servs, Maintains $360 Price Target"
              },
              {
                "id": 140502247,
                "url": "https://finnhub.io/api/news?id=d7bf6edac320216b9740fe32514bc8461a205ee6f62fe0a5a3f1c83633723bff",
                "image": "",
                "source": "Benzinga",
                "related": "WST",
                "summary": "Wolfe Research  analyst Mike Polark   assumes West Pharmaceutical Servs (NYSE:WST) with a Outperform rating.",
                "category": "company",
                "datetime": 1780389057,
                "headline": "Wolfe Research Assumes West Pharmaceutical Servs at Outperform"
              },
              {
                "id": 140493471,
                "url": "https://finnhub.io/api/news?id=a1c2edf502bfb2859b83b8849116be44b8e1d88763cb8fcca14e95fc01ec2bdc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its Board of Directors has appointed Michel Lagarde to be President and Chief Executive Officer (CEO) and a member of the Company's Board of Directors starting August 31, 2026. He succeeds Eric M. Green, who will retire from his roles as President, CEO and Board Chair on that date. The Company also announced as part of the CEO transition that the Board",
                "category": "company",
                "datetime": 1780345800,
                "headline": "West Appoints Michel Lagarde to be President and Chief Executive Officer"
              },
              {
                "id": 140491518,
                "url": "https://finnhub.io/api/news?id=7715f06b028c15cfd0883880f5b5e8dad289dc73ae18c028eb2f9cb92e48a24d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Natera teams with Diakonos to use Signatera MRD testing in a refractory melanoma immunotherapy trial, tracking ctDNA to gauge response.",
                "category": "company",
                "datetime": 1780333740,
                "headline": "NTRA & Diakonos Partner to Use Signatera in Refractory Melanoma Trial"
              },
              {
                "id": 140489989,
                "url": "https://finnhub.io/api/news?id=e649264ac6f1ebea014950bc3449f38702dbd354f0df843c534f41a0575176cb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "PACB expands HiFi sequencing reach with commercial availability of SPRQ-Nx for Revio, lowering costs by about 30% and adding AI and epigenetics upgrades.",
                "category": "company",
                "datetime": 1780326540,
                "headline": "PacBio Expands HiFi Sequencing Reach With New SPRQ-Nx Technology"
              },
              {
                "id": 140460561,
                "url": "https://finnhub.io/api/news?id=0ef0d13582f6e663c993edb199983b88a63a47887e5be779decc929f915ac6f6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1780068609,
                "headline": "Align Technology (ALGN) Down 1.6% Since Last Earnings Report: Can It Rebound?"
              },
              {
                "id": 140458485,
                "url": "https://finnhub.io/api/news?id=1d30f9f4e86ac10b9f4bdca2646a378a6ae9378669f7df09ed5ee2559dfca4ec",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "HQY tops Q1 FY27 EPS and revenue estimates as HSA accounts and assets climb, and guidance for FY27 revenues and adjusted EPS rises.",
                "category": "company",
                "datetime": 1780066380,
                "headline": "HealthEquity Stock Gains as Q1 Earnings Top Estimates, Revenues Up Y/Y"
              },
              {
                "id": 140472968,
                "url": "https://finnhub.io/api/news?id=5f623e429ab8bc5a165e7152e24bad61c4766ce54d4666f4e16801a3d6a71d1b",
                "image": "",
                "source": "Benzinga",
                "related": "WST",
                "summary": "Morgan Stanley  analyst Kallum Titchmarsh   maintains West Pharmaceutical Servs (NYSE:WST) with a Equal-Weight and raises the price target from $315 to $325.",
                "category": "company",
                "datetime": 1780054716,
                "headline": "Morgan Stanley Maintains Equal-Weight on West Pharmaceutical Servs, Raises Price Target to $325"
              },
              {
                "id": 140445072,
                "url": "https://finnhub.io/api/news?id=a610351807a30d758989a994c957be2f59fd06adcff19aa361bed18654dc9cf1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "NTRA upgrades Panorama NIPT with SNP-informed deep sequencing, validated for low fetal fraction to cut no-calls and boost reliable prenatal results.",
                "category": "company",
                "datetime": 1779980640,
                "headline": "Natera to Launch Enhanced Panorama NIPT for Low Fetal Fractions"
              },
              {
                "id": 140434912,
                "url": "https://finnhub.io/api/news?id=d9fc06c8f2e87143c3bd984ab63c962cb2d9d9cccb5d506baed6d920936710bc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "SYK launches Pangea Plating System in Europe, completing its first London case as it broadens trauma care solutions for many fractures.",
                "category": "company",
                "datetime": 1779896340,
                "headline": "Stryker Launches Pangea Plating System in Europe for Fracture Fixation"
              },
              {
                "id": 140431511,
                "url": "https://finnhub.io/api/news?id=4f51e0755e4c6462f6df6804c20c6e71683e99076fdc3e862f826a60fbf02c75",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2209914068/image_2209914068.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "WST",
                "summary": "The Dividend Aristocrats underperformed SPY YTD, returning 3.34% versus SPY's 10.39%, though 22 Aristocrats still posted double-digit gains.",
                "category": "company",
                "datetime": 1779871416,
                "headline": "Best Dividend Aristocrats: May 2026"
              },
              {
                "id": 140422922,
                "url": "https://finnhub.io/api/news?id=5185a872bf28645d0a7740203e50cac87714254764a449d0f918e4be669e014e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "BTSG leans on surging Specialty & Infusion and integrated home health branches, but IRA and generic shifts may pressure 2026 margins.",
                "category": "company",
                "datetime": 1779811260,
                "headline": "Here's Why You Should Add BrightSpring Stock to Your Portfolio Now"
              },
              {
                "id": 140421417,
                "url": "https://finnhub.io/api/news?id=5ca179be283cc52ac0e6856cef034e9d934e587c57061800a0dccdc9427c4550",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "NTRA is expanding in Austin with what it says will be the world's largest sequencing capacity as oncology testing demand keeps surging.",
                "category": "company",
                "datetime": 1779807480,
                "headline": "Natera Expands Austin Operations With New Sequencing Facility"
              },
              {
                "id": 140426213,
                "url": "https://finnhub.io/api/news?id=c7d1b6130c115637825b03cab5b8f2e0e7f4ad064d8236f45329a4d095cf0f3d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services has considerably outperformed the broader market over the past 52 weeks, and Wall Street analysts maintain a highly optimistic outlook about the stock’s prospects.",
                "category": "company",
                "datetime": 1779806505,
                "headline": "Is Wall Street Bullish or Bearish on West Pharmaceutical Services Stock?"
              },
              {
                "id": 140414650,
                "url": "https://finnhub.io/api/news?id=95eeed52920380b649977145a2d60a7c800c2b061161a4e95fdf5c0ed7b99572",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Recent performance snapshot West Pharmaceutical Services (WST) has drawn investor attention after a period of solid share performance, with the stock roughly flat over the past day but higher over the past week, month and past 3 months. At a recent close of US$316.42, West Pharmaceutical Services sits on a market value of about US$22.35b, alongside reported annual revenue of US$3.22b and net income of US$542.7m from its injectable drug packaging and delivery business. See our latest analysis...",
                "category": "company",
                "datetime": 1779743540,
                "headline": "A Look At West Pharmaceutical Services (WST) Valuation After Recent Share Price Momentum"
              },
              {
                "id": 140412105,
                "url": "https://finnhub.io/api/news?id=c36321df2f45eca41091edb2445050975192f64b9534f980847b0c1917ac81ec",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "GEHC teams with UW Medicine Radiology to advance CT and molecular imaging, aiming to automate workflows and speed next-gen imaging to clinics.",
                "category": "company",
                "datetime": 1779721140,
                "headline": "GE HealthCare and UW Medicine Radiology Expand CT, MI Research Tie"
              },
              {
                "id": 140397434,
                "url": "https://finnhub.io/api/news?id=d7fd9fa7df3d8cb9e54856fe4a536db2d6b33b5b6e8ca948866e0cfb7e6df209",
                "image": "https://www.chartmill.com/images/uploads/minervini_news_8825971f4b.webp",
                "source": "ChartMill",
                "related": "WST",
                "summary": "West Pharmaceutical Services (WST) passes the Minervini Trend Template with perfect moving average alignment and strong relative strength, combined with accelerating 46.9% EPS growth and 21% revenue growth, making it a high-momentum growth stock to watch.",
                "category": "company",
                "datetime": 1779537636,
                "headline": "West Pharmaceutical Services (NYSE:WST) Shows Explosive Potential with Perfect Minervini Trend Template and Accelerating Growth"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 4,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.2,
            "source_article_count": 75,
            "discarded_article_count": 64
          },
          "sentimentPoints": 6
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 11,
        "grade": "較差",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 0.5,
          "macdPoints": 0.8,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.5,
            "vcp_reason": "升放量(近10日2日)；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 3,
              "vol_ref": 861046.6666666666,
              "down_days": 6,
              "vcp_ready": false,
              "above_ma50": false,
              "avg_vol_10": 1229380,
              "avg_vol_20": 936240,
              "avg_vol_30": 861046.6666666666,
              "range_pct_10": 0.21272294918215975,
              "range_pct_20": 0.2549753043187321,
              "range_pct_30": 0.2549753043187321,
              "up_expand_ok": true,
              "lookback_used": 79,
              "near_20d_high": false,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 2,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.4277739495342878,
              "dist_to_20d_high": 0.2015581371405038,
              "down_shrink_days": 1,
              "breakout_level_20d": 291.38,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.8342884411905447
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 0.8,
          "volumeWeight": 2,
          "maCrossPoints": 0,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "較差",
        "items": {
          "position": {
            "score": 1.1,
            "details": {
              "atrPct": 4.098732177035554,
              "turnoverUsdM": 216.41102069800002,
              "liquidityPoints": 0.4,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.WST",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 213.5786,
            "strength_details": {
              "ma_score": 1,
              "atr_score": 1,
              "rsi_score": 2.5,
              "macd_score": 1,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 8.2,
            "take_profit_price": 245.8728,
            "target_multiplier": 1.6,
            "technical_strength": 1.3,
            "take_profit_percent": 5.7
          },
          "positionPoints": 1.1,
          "stopLossPoints": 1.2,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 8.197464354071109,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 78.57,
    "atr": {
      "atr": 9.5357,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 4.1
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": -130.65
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.0355
    },
    "kdj": {
      "d": 14.99,
      "j": 6.7,
      "k": 12.22,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "超賣或超買風險",
      "score": 2,
      "value": 35.76
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 2,
      "trend": "資金流出",
      "value": -12646000,
      "recentSlope": -595160,
      "previousSlope": 231370
    },
    "rsi": 22.39,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 269.1886,
      "position": "SAR喺價上",
      "distancePct": 15.71,
      "previousTrend": "下降"
    },
    "ma50": 267.9744,
    "macd": {
      "macd": -10.035377815596235,
      "trend": "看跌",
      "signal": -6.311039046486341,
      "histogram": -3.7243387691098935
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 258.6034,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.96,
      "score": 4,
      "avgVolume": 964920,
      "currentVolume": 930200
    },
    "derived": {
      "ma20": 262.004,
      "ma50": 267.9744,
      "prevClose": 235.89,
      "avgVolume10": 1249830,
      "avgVolume20": 964920,
      "changePercent": -1.37,
      "avgVolumeForScore": 964920
    },
    "ma_cross": {
      "ma20": 262.004,
      "ma50": 267.9744,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "熊勢",
      "score": 0,
      "prevMa20": 264.215,
      "prevMa50": 268.5486,
      "spreadPct": 2.23,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 227.955,
      "upper": 296.053,
      "position": "中間"
    },
    "rsi_short": 14.82,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.96
    }
  }
}

Raw metrics JSON

 
{
  "close": 232.65,
  "volume": 930200,
  "changePercent": -1.37
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.